Juvena CEO, Hanadie Yousef, Explores the Future of the Intersection of Technology and Biology Alongside Silicon Valley Entrepreneurs with Middle East & Northern African roots at the Annual TechWadi Forum
Biocom California Names Juvena CEO Hanadie Yousef as One of Ten Recipients of Its 7th Annual Catalyst Award, Recognizing the Most Inspiring and Driven Minds Sparking Meaningful Change to Human Health
Discussing longevity insights among financial and biotech leaders at the BioFuture Conference, Juvena CEO, Hanadie Yousef, PhD explores the role of secreted proteins in targeting chronic and age-related diseases.
Juvena’s CSO, Dr. O’Connell, was an invited speaker at the 6th Annual Fibrotic Drug Discovery Summit in Nov. 2022 and discussed how decoding stem cell secreted proteins can enable drug discovery for fibrotic degenerative diseases, providing an overview of Juvena’s pulmonary and hepatic programs.
Annual BioFuture 2022 Event Recognizes Juvena CEO Dr. Hanadie Yousef Among Longevity Pioneers Shaping Expectations in Healthcare and Celebrates the Company’s Series A Announcement
Juvena Therapeutics is recognized for its transformative science that targets unmet medical needs as well as for the quality of its management team as part of the Emerging Company Showcase at the prestigious Life Sciences Summit.
Juvena CEO, Hanadie Yousef, PhD, discusses the market opportunity for their unique discovery platform for mapping secreted proteins to unmet medical needs leading to their growing pipeline of biologics for rare and chronic diseases to senior leaders of Mubadala’s LP.
To help drive change in biotech, Dr. Hanadie Yousef joined the industry’s leading women CEOs and investors at the first joint Women Investors and CEOs networking event hosted by Sofinnova Investments and Cowen. Together these women are driven to create positive change in the industry, improving diversity among biotech c-suite and investors and supporting one another.
Horizon Ventures Techcracker conference spotlights Juvena Co-Founder, Hanadie Yousef, PhD as one of 70 founders of innovative new companies developing disruptive technologies that improve lives Oct. 2022
At the Myotonic Dystrophy Foundation Annual conference Juvena Therapeutics joins a community of advocates, people who suffer from this most common muscular dystrophy, their families, caregivers, clinical leaders and experts, and Industry leaders developing therapeutics for this major unmet medical need Sept. 2022
